Fusion Pharm Stock Forecast - Daily Balance Of Power

FSPM Stock  USD 0.0001  0.00  0.00%   
Fusion Stock Forecast is based on your current time horizon. Although Fusion Pharm's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Fusion Pharm's systematic risk associated with finding meaningful patterns of Fusion Pharm fundamentals over time.
  
At this time, Fusion Pharm's Other Current Liabilities is very stable compared to the past year. As of the 11th of December 2024, Other Assets is likely to grow to 311.54, while Total Current Liabilities is likely to drop 5,325.
On March 21, 2024 Fusion Pharm had Daily Balance Of Power of 0. Balance of Power indicator (or BOP) measures the strength of Fusion Pharm market sensitivity to bulls and bears. It estimates the ability of Fusion Pharm buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Fusion Pharm Balance of Power indicator one can determine a trend of the price direction.
Check Fusion Pharm VolatilityBacktest Fusion PharmTrend Details  

Fusion Pharm Trading Date Momentum

On March 22 2024 Fusion Pharm was traded for  0.0001  at the closing time. The top price for the day was 0.0001  and the lowest listed price was  0.0001 . There was no trading activity during the period 1.0. Lack of trading volume on March 22, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.00% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Fusion Pharm to competition

Other Forecasting Options for Fusion Pharm

For every potential investor in Fusion, whether a beginner or expert, Fusion Pharm's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Fusion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Fusion. Basic forecasting techniques help filter out the noise by identifying Fusion Pharm's price trends.

Fusion Pharm Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Fusion Pharm stock to make a market-neutral strategy. Peer analysis of Fusion Pharm could also be used in its relative valuation, which is a method of valuing Fusion Pharm by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Fusion Pharm Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Fusion Pharm's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Fusion Pharm's current price.

Fusion Pharm Market Strength Events

Market strength indicators help investors to evaluate how Fusion Pharm stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fusion Pharm shares will generate the highest return on investment. By undertsting and applying Fusion Pharm stock market strength indicators, traders can identify Fusion Pharm entry and exit signals to maximize returns.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Fusion Pharm is a strong investment it is important to analyze Fusion Pharm's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fusion Pharm's future performance. For an informed investment choice regarding Fusion Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Fusion Pharm to cross-verify your projections.
To learn how to invest in Fusion Stock, please use our How to Invest in Fusion Pharm guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion Pharm. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.15)
Revenue Per Share
0.133
Return On Assets
(1.38)
The market value of Fusion Pharm is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion Pharm's value that differs from its market value or its book value, called intrinsic value, which is Fusion Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion Pharm's market value can be influenced by many factors that don't directly affect Fusion Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.